Evia Bio™ is a life science innovation company enabling the growing cell therapy market. We provide new non-DMSO cryopreservation solutions developed by world-leading cryobiologist, Allison Hubel, PhD. We partner with cell therapy companies looking to advance their products to clinical trials and commercialization. Our solutions unlock the full potential of emerging life-saving therapies through the use of all-natural organic compounds to protect the integrity of cells during cryopreservation and patient safety at the point of care. Please visit www.eviabio.com.
| Website | https://eviabio.com/ |
| Employees | 10 (5 on RocketReach) |
| Address | 2001 6th ST SE Room 2-434, Minneapolis, Minnesota 55455, US |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Cryopreservation, Biotechnology, Cell Therapies, Regenerative Medicine, Biopreservation, Pharmaceutical, Biomedical, Drug Delivery, Clinical Trials, Fda Approval, Stem Cells, Cell Culture, Biomanufacturing, Medical Devices, Pharmaceutical Research, Bioscience, Healthcare |
| Competitors | Arcadia Biosciences, Corteva Agriscience, Syngenta, Bayer, BASF, Monsanto Company Named, Geno, Cibus, DuPont Pioneer, KWS Group +30 more (view full list) |
Looking for a particular Evia Bio employee's phone or email?
Jeffrey Allen is the Chairman and CEO of Evia Bio.
5 people are employed at Evia Bio.
Evia Bio is based in Minneapolis, Minnesota.